The efficacy of rituximab in patients with neuromyelitis optica spectrum disorder: A real-world study from Turkey.
Cihat UzunköprüMelih TutuncuTuncay GündüzHaluk GümüşKerim AslanSerkan DemirBilge Piri CinarHatice Sabiha TüreUgur UygunogluRıfat Erdem ToğrolMurat TerziMurat KürtüncüSerkan ÖzakbaşMesude TütüncüYesim BeckmannAksel SivaPublished in: International journal of clinical practice (2021)
Rituximab therapy is efficacious in the treatment of Turkish NMOSD patients independent of the presence of the anti-AQP4-IgG antibody.